TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

Rosen Law Firm reminds investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) who purchased securities between February 21, 2025 and August 28, 2025 of the January 9, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Telix made materially false and misleading statements regarding progress on prostate cancer therapeutics, supply chain quality, and business prospects.

Insights
JPMpJ   positive

Set a fresh record, stock price increased 1.90%


TLX   negative

The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding prostate cancer therapeutic progress, supply chain quality, and business operations. Investors who purchased during the class period may have suffered damages.